128
Contineum Therapeutics, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY24:
206
FY25:
268
(positive)
Change from FY23 to FY25
millions USD
FY23:
2.68
FY24:
6.46
FY25:
8.73
Total assets
Change from FY23 to FY25
millions USD
FY23:
130
FY24:
213
FY25:
277
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
5.48
FY24:
9.97
FY25:
9.74
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.22
FY24:
4.81
FY25:
5.91
(positive)
Change from FY23 to FY25
millions USD
FY23:
−67.9
FY24:
198
FY25:
261
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
213
FY25:
277
All amounts in millions USD